Professional Summary
Specializing In
Practice Locations
Referring Physicians
Biography
I am originally from San Diego, California where I attended medical school and did a surgical internship at UCSD. While there, I was exposed to the field of Nuclear Medicine and became fascinated by molecular imaging and the burgeoning field of theragnostics. I chose the Nuclear Medicine residency program at Stanford because it is one of the premier molecular imaging programs in the world, where some of the best known physicians and scientists in the field are located. Situated in Silicon Valley and rooted in a culture of collaboration, Stanford reaps the benefits from being at the intersection of technology, innovation, engineering and science to produce ground breaking research that continually pushes the imagination and limits of Nuclear Medicine. I am honored to be able to pursue my clinical interests and further my career in this environment.
View Full Biography
Professional Summary
Education & Certifications
- Medical Education: University of California San Diego School of Medicine (2008) CA
- Residency: Stanford University Nuclear Medicine Residency (2013) CA
- Internship: UCSD Surgery Residency (2009) CA
Honors & Awards
- Norman D Poe Memorial Scholarship Award for MD In-Training, Western Regional Society of Nuclear Medicine meeting (October 2011)
Memberships
- member, Society of Nuclear Medicine (2010 - Present)
Publications
-
Review of utilization of surveillance scans in lymphoma patients: A pilot study
Judy Nguyen, Xiong, W., & Goris, M. (2011). Review of utilization of surveillance scans in lymphoma patients: A pilot study. JOURNAL OF NUCLEAR MEDICINE. SOC NUCLEAR MEDICINE INC. -
Prognostic value of volumetric PET parameters at early response evaluation in melanoma patients treated with immunotherapy.
Nakamoto, R., Zaba, L. C., Rosenberg, J., Reddy, S. A., Nobashi, T. W., Davidzon, G., … Franc, B. L. (2020). Prognostic value of volumetric PET parameters at early response evaluation in melanoma patients treated with immunotherapy. European Journal of Nuclear Medicine and Molecular Imaging. -
Imaging Characteristics and Diagnostic Performance of 2-deoxy-2-[18F]fluoro-D-Glucose PET/CT for Melanoma Patients Who Demonstrate Hyperprogressive Disease When Treated with Immunotherapy.
Nakamoto, R., C Zaba, L., Rosenberg, J., Arani Reddy, S., W Nobashi, T., Ferri, V., … Lewis Franc, B. (2020). Imaging Characteristics and Diagnostic Performance of 2-deoxy-2-[18F]fluoro-D-Glucose PET/CT for Melanoma Patients Who Demonstrate Hyperprogressive Disease When Treated with Immunotherapy. Molecular Imaging and Biology. -
Obituary for Sanjiv Sam Gambhir, MD, PhD.
Davidzon, G., Franc, B., Mari Aparici, C., Moradi, F., Nguyen, J., & Iagaru, A. (2020). Obituary for Sanjiv Sam Gambhir, MD, PhD. Clinical Nuclear Medicine. -
Imaging characteristics and diagnostic performance of F-18-FDG PET/CT for melanoma patients who demonstrate hyperprogressive disease when treated with immunotherapy
Nakamoto, R., Zaba, L., Rosenberg, J., Reddy, S., Nobashi, T., Davidzon, G., … Franc, B. (2020). Imaging characteristics and diagnostic performance of F-18-FDG PET/CT for melanoma patients who demonstrate hyperprogressive disease when treated with immunotherapy. JOURNAL OF NUCLEAR MEDICINE. SOC NUCLEAR MEDICINE INC. -
Prognostic value of volumetric PET parameters at early response evaluation in melanoma patients treated with immunotherapy
Nakamoto, R., Zaba, L., Rosenberg, J., Reddy, S., Nobashi, T., Davidzon, G., … Franc, B. (2020). Prognostic value of volumetric PET parameters at early response evaluation in melanoma patients treated with immunotherapy. JOURNAL OF NUCLEAR MEDICINE. SOC NUCLEAR MEDICINE INC. -
PSMA-and GRPR-targeted PET: Preliminary Results in Patients with Biochemically Recurrent Prostate Cancer
Baratto, L., Duan, H., Hatami, N., Song, H., Davidzon, G., Franc, B., … Iagaru, A. (2020). PSMA-and GRPR-targeted PET: Preliminary Results in Patients with Biochemically Recurrent Prostate Cancer. JOURNAL OF NUCLEAR MEDICINE. SOC NUCLEAR MEDICINE INC. -
The Clinical Utility of 18F-Fluciclovine PET/CT in Biochemically Recurrent Prostate Cancer: an Academic Center Experience Post FDA Approval.
Nakamoto, R., Harrison, C., Song, H., Guja, K. E., Hatami, N., Nguyen, J., … Iagaru, A. (2021). The Clinical Utility of 18F-Fluciclovine PET/CT in Biochemically Recurrent Prostate Cancer: an Academic Center Experience Post FDA Approval. Molecular Imaging and Biology. -
Prognostic value of bone marrow metabolism on pretreatment 18F-FDG PET/CT in patients with metastatic melanoma treated with anti-PD-1 therapy.
Nakamoto, R., Zaba, L. C., Liang, T., Reddy, S. A., Davidzon, G., Aparici, C. M., … Franc, B. L. (2021). Prognostic value of bone marrow metabolism on pretreatment 18F-FDG PET/CT in patients with metastatic melanoma treated with anti-PD-1 therapy. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. -
PROSPECTIVE EVALUATION OF F-18-DCFPYL PET/CT IN BIOCHEMICALLY RECURRENT PROSTATE CANCER: ANALYSIS OF F-18-DCFPYL UPTAKE IN POSSIBLE EXTRA-PELVIC OLIGOMETASTASES
Song, H., Nguyen, J., Moradi, F., Aparici, C. M., Franc, B., Davidzon, G., & Iagaru, A. (2021). PROSPECTIVE EVALUATION OF F-18-DCFPYL PET/CT IN BIOCHEMICALLY RECURRENT PROSTATE CANCER: ANALYSIS OF F-18-DCFPYL UPTAKE IN POSSIBLE EXTRA-PELVIC OLIGOMETASTASES. JOURNAL OF UROLOGY. LIPPINCOTT WILLIAMS & WILKINS. -
Perfusion Only Scans with and without SPECT/CT in the Era of COVID-19
Zhang, R., Moradi, F., Aparici, C. M., Davidzon, G., Nguyen, J., Iagaru, A., & Franc, B. (2021). Perfusion Only Scans with and without SPECT/CT in the Era of COVID-19. JOURNAL OF NUCLEAR MEDICINE. SOC NUCLEAR MEDICINE INC. -
Peptide Receptor Radionuclide Therapy (PRRT) in Advanced Pheochromocytoma and Paraganglioma From a Single Institution Experience
Duan, H., Ferri, V., Fisher, G. A., Shaheen, S., Davidzon, G. A., Moradi, F., … Aparici, C. M. (2022). Peptide Receptor Radionuclide Therapy (PRRT) in Advanced Pheochromocytoma and Paraganglioma From a Single Institution Experience. PANCREAS. LIPPINCOTT WILLIAMS & WILKINS. -
Ultrasound Evaluation of Regional Breast Lymph Nodes
Ojeda-Fournier, H., & Nguyen, J. Q. (2011). Ultrasound Evaluation of Regional Breast Lymph Nodes. SEMINARS IN ROENTGENOLOGY, 46(1), 51–59. -
How to improve your breast cancer program: Standardized reporting using the new American College of Radiology Breast Imaging-Reporting and Data System.
Ojeda-Fournier, H., & Nguyen, J. Q. (2009). How to improve your breast cancer program: Standardized reporting using the new American College of Radiology Breast Imaging-Reporting and Data System. The Indian Journal of Radiology & Imaging, 19(4), 266–77. -
Early degradation and serum appearance of type I collagen fragments after myocardial infarction
Villarreal, F., Omens, J., Dillmann, W., Risteli, J., Nguyen, J., & Covell, J. (2004). Early degradation and serum appearance of type I collagen fragments after myocardial infarction. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 36(4), 597–601. -
Early short-term treatment with doxycycline modulates postinfarction left ventricular remodeling
Villarreal, F. J., Griffin, M., Omens, J., Dillmann, W., Nguyen, J., & Covell, J. (2003). Early short-term treatment with doxycycline modulates postinfarction left ventricular remodeling. CIRCULATION, 108(12), 1487–1492.
Clinical Trials
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Practice Locations
Nuclear Medicine and Molecular Imaging Stanford, CA
Stanford, CA
Nuclear Medicine and Molecular Imaging
300 Pasteur Drive, 2nd Floor, C21
Stanford , CA 94305
Make An Appointment More Clinic Information Getting HereImportant Information about Our Organizations and Physician Affiliation
Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.
Referring Physicians
PHYSICIAN HELPLINE
Phone: 1-866-742-4811
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.
You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.
- Send referrals online
- Place radiology and lab orders
- View referral status
- Access medical records